Health News Archive - February 09, 2010

HOLLISTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc., ("Nyer") has notified the NASDAQ Stock Market ("NASDAQ") of its intent to voluntarily delist its securities following its closings of the sales of substantially all of its assets.

IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced financial guidance for the full year 2010. The Company expects net revenue will be approximately $147 to $165 million.

FORT WORTH, Texas, Feb. 9 /PRNewswire/ -- Healthpoint today announced it has provided research grants to the University of Florida, Gainesville, and Vanderbilt University School of Medicine to support a joint study evaluating bioburden and potential healing markers in chronic wounds.

PURCHASE, N.Y., Feb. 9 /PRNewswire-FirstCall/ -- PepsiCo, Inc.

Calorie information to be added to the front of beverage containers, vending machines and fountain equipment, raising awareness wherever beverages are purchased WASHINGTON, Feb.

In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Chicago Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK.

Senator addresses XLHealth practitioners who offer in-home assistance to chronically ill seniors through first-of-its-kind HouseCalls Program BALTIMORE, Feb.

SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX) announced today results for the three and nine months ended December 31, 2009. Net sales decreased 15% for the third quarter of fiscal year 2010 to $1,765,000 from $2,084,000 for the same period of last year.

Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen's University researchers have discovered

Word of the Day
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.